X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
0
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.fiercepharma.com/pharma/ptcs-re-examination-bid-dmd-drug-translarna-falls-short-europe
https://www.ema.europa.eu/en/news/ema-recommends-non-renewal-authorisation-duchenne-muscular-dystrophy-medicine-translarna
https://www.fiercepharma.com/pharma/nice-recommends-two-rare-disease-therapies-ptc-therapeutics-and-alnylam
https://www.prnewswire.com/news-releases/ptc-therapeutics-to-present-clinical-and-real-world-evidence-on-translarna-at-the-annual-congress-of-the-world-muscle-society-301645587.html
https://pharmaphorum.com/news/translarna-not-approved-by-nice-for-dmd-on-nhs/
https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-call-to-review-topline-results-from-study-041-for-translarna-ataluren-in-nonsense-mutation-duchenne-muscular-dystrophy-301571349.html
https://www.prnewswire.com/news-releases/ptc-announces-expansion-of-translarna-label-to-include-ambulatory-patients-as-young-as-2-years-old-in-brazil-301407178.html
https://www.prnewswire.com/news-releases/stride-data-show-translarna-delays-loss-of-ambulation-by-more-than-five-years-in-boys-with-nonsense-mutation-duchenne-muscular-dystrophy-301380360.html
https://www.biopharmadive.com/news/ptc-duchenne-data-fourth-fda-review/594642/
https://finance.yahoo.com/news/ptc-therapeutics-announces-first-publication-130000888.html
https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-new-real-world-analysis-demonstrating-translarna-ataluren-slows-disease-progression-in-patients-with-duchenne-muscular-dystrophy-300931088.html
http://www.pharmatimes.com/news/az_bags_two_extensions_in_latest_chmp_decisions_1292946
http://www.pmlive.com/pharma_news/mallinckrodt_doses_first_patient_in_muscular_dystrophy_trial_1246911
http://ir.ptcbio.com/news-releases/news-release-details/ptc-therapeutics-announces-positive-data-its-translarnatm-phase
https://www.prnewswire.com/news-releases/ptc-therapeutics-announces-positive-data-from-its-translarna-phase-ii-clinical-trial-in-children-as-young-as-two-years-with-nonsense-mutation-duchenne-muscular-dystrophy-300677534.html
http://ir.ptcbio.com/news-releases/news-release-details/chmp-adopts-positive-opinion-expansion-translarnatm-ataluren
https://endpts.com/the-fda-and-the-ema-go-their-separate-ways-on-dmd-chmp-slaps-down-sarepta-but-offers-rival-ptc-an-expanded-market/
Market Place
Share 
